论文部分内容阅读
目的:分析小儿肺炎支原体肺炎的临床特点,为临床治疗提供依据。方法:回顾2012年6月～2013年3月肺炎支原体肺炎患儿40例,男22例,女18例,将其分成实验组20例,对照组20例,采用阿奇霉素序贯疗法治疗实验组患儿;采用红霉素序贯疗法治疗对照组患儿,对比两组患儿治疗总有效率与不良反应发生率。结果:从治疗总有效率角度看,实验组为95%,对照组为80%,从不良反应发生率角度看,实验组为5%,对照组为20%,与对照组相比,实验组小儿肺炎支原体肺炎的治疗效果更佳。P<0.05,差异显著,具有统计学意义。结论:对于小儿肺炎支原体肺炎,采用阿奇霉素序贯疗法,小儿不良反应发生率低,并发症少,临床效果显著,在实际治疗中应用阿奇霉素序贯疗法具有十分积极的意义。
Objective: To analyze the clinical features of children with Mycoplasma pneumoniae pneumonia and provide the basis for clinical treatment. Methods: From June 2012 to March 2013, 40 children with Mycoplasma pneumoniae pneumonia were retrospectively studied, including 22 males and 18 females, which were divided into experimental group (20 cases) and control group (20 cases). The patients were treated with azithromycin sequential therapy Children; using erythromycin sequential therapy in children with control group, compared the two groups of children with total effective rate of treatment and adverse reactions. Results: From the perspective of total effective rate, the experimental group was 95% and the control group was 80%. From the point of adverse reaction rate, the experimental group was 5% and the control group was 20%. Compared with the control group, Pediatric pneumonia mycoplasma pneumonia treatment effect is better. P <0.05, significant difference, with statistical significance. Conclusion: For children with Mycoplasma pneumoniae pneumonia, with azithromycin sequential therapy, the incidence of adverse reactions in children with low, fewer complications, the clinical effect is significant, in the actual treatment of azithromycin sequential therapy has a very positive significance.